RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

National Institutes of Health

A collection of news and information related to National Institutes of Health published by this site and its partners.

Top National Institutes of Health Articles

Displaying items 45-55
  • Ice bucket challenge heats up ALS donations

    Ice bucket challenge heats up ALS donations
    The ice bucket challenge has helped the local Les Turner ALS Foundation raise $550,000 more in recent weeks than it did during the same period last year — a nearly 600 percent increase in donations over the first three weeks of August. But that...
  • Nail polish that detects date-rape drugs stirs a storm

    Nail polish that detects date-rape drugs stirs a storm
    Four N.C. State University students have dreamed up a striking way to detect date rape drugs that's getting some major media buzz. It's also generating a backlash from people who say it doesn't get at the root causes of rape. The idea: nail polish...
  • Medical research rarely uses female test subjects

    Medical research rarely uses female test subjects
    Women and men often react differently to illness and treatment, yet surgical researchers rarely use female animals or cells in their published studies — to the detriment of patients, a Northwestern University professor has concluded. Dr. Melina R....
  • Video: Watch this boy born deaf hear music for the first time

    Video: Watch this boy born deaf hear music for the first time
    A 3-year-old boy who was born deaf has been caught reacting to music for the first time — and it looks like he’s ready to bust a move. In the home video, Auguste Majkowski listens with a smile on his face to a 1977 tune called “Ma...
  • NIH to launch Ebola vaccine trials in humans

    NIH to launch Ebola vaccine trials in humans
    The National Institutes of Health has announced the first clinical trial of a vaccine to protect healthy people from infection by the Ebola virus, which is responsible for an estimated 1,550 deaths throughout West Africa. NIH Director Francis Collins...
  • Ebola vaccine to be tested on human volunteers, starting in September

     Ebola vaccine to be tested on human volunteers, starting in September
    GlaxoSmithKline announced Thursday, Aug. 28, that it will begin testing its Ebola vaccination as early as mid-September in human volunteers    With the help of the National Institutes of Health’s Vaccine Research Center, GSK will start...
  • BioCryst expects to begin Ebola study in weeks

    (Reuters) - BioCryst Pharmaceuticals Inc said it expects to initiate a study within weeks to test its antiviral in primates for use against Ebola infections The biotechnology company's stock was up about 5.4 percent in premarket trading after it also...
  • White House orders U.S. labs to take inventory of infectious agents

    CHICAGO (Reuters) - The White House has ordered federally funded labs working with infectious agents to conduct an immediate inventory of the pathogens in their labs and review their safety and security protocols, according to a memo released on Thursday....
  • Vacuna de GSK para el ébola entra en vía rápida para pruebas clínicas

    LONDRES/NUEVA YORK (Reuters) - Una vacuna experimental para el ébola de GlaxoSmithKline será llevada rápidamente a estudios en humanos y la compañía planea elaborar existencias de hasta 10.000 dosis para un despliegue de emergencia si los resultados son...
  • U.S. speeds up human clinical trials for promising Ebola vaccine

    U.S. speeds up human clinical trials for promising Ebola vaccine
    Researchers at the National Institutes of Health are accelerating human clinical trials for what scientists hope is a promising new vaccine to combat the deadly Ebola virus. Phase 1 of the clinical trials, which were previously not expected to begin...
  • Ebola vaccine from GSK fast-tracked into clinical trials

    LONDON/NEW YORK (Reuters) - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into human studies and the company plans to build a stockpile of up to 10,000 doses for emergency deployment, if results are good. The research work...